Author

C. K. Kang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Research Focus:differential expression· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

M.-d. Oh· 3 shared P. G. Choe· 3 shared S. Kim· 3 shared W. B. Park· 3 shared D. K. Yoo· 2 shared E. S. Kim· 2 shared H. B. Kim· 2 shared J. Chung· 2 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M.-d. Oh

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An ancestral vaccine induces anti-Omicron antibodies by hypermutation

S. Park, J. Choi, Y. Lee, J. Noh, N. Kim, J. Lee, G. Cho, S. Kim, D. K. Yoo, C. K. Kang, P. G. Choe, N. J. Kim, W. B. Park, S. Kim, M.-d. Oh, , J. Chung

This study shows that repeated mRNA vaccination leads to BCR hypermutation, enabling antibodies to neutralize Omicron variants.

bioRxiv · Mar 15, 2023Bioengineering

Clinical and immunological signatures of severe COVID-19 in previously healthy patients with clonal hematopoiesis

C. K. Kang, B. Choi, S. Kim, S. Park, S. H. Yoon, D. Lee, A. Lee, Y. Ko, E. Chang, J. Jung, P. G. Choe, W. B. Park, E. S. Kim, H. B. Kim, N. J. Kim, , I. Jung

This study identifies clonal hematopoiesis as an independent risk factor for severe COVID-19 in previously healthy patients, revealing distinct immunological and epigenetic signatures.

bioRxiv · Oct 5, 2021 · PreprintImmunology

Stereotypic Neutralizing VH Clonotypes Against SARS-CoV-2 RBD in COVID-19 Patients and the Healthy Population

S. I. Kim, J. Noh, S. Kim, Y. Choi, D. K. Yoo, Y. Lee, H. Lee, J. Jung, C. K. Kang, K.-H. Song, P. G. Choe, H. B. Kim, E. S. Kim, N.-J. Kim, M.-W. Seong, , J. Chung

The paper identifies stereotypic VH clonotypes against SARS-CoV-2 RBD in patients and healthy individuals, showing their pre-existing presence in the healthy population.

bioRxiv · Jun 26, 2020 · PreprintImmunology